These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30553749)

  • 21. [Role of simple noninvasive markers of liver fibrosis in qualification to treatment in patients with chronic hepatitis C].
    Gietka JA
    Przegl Epidemiol; 2011; 65(1):27-34. PubMed ID: 21735832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
    van der Meer AJ; Maan R; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Manns MP; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1168-76. PubMed ID: 26647353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Histological evaluation of liver in chronic hepatitis C after direct-acting antiviral agents treatment].
    Jiang LN; Zhao JM
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):184-187. PubMed ID: 29804391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
    Jacobson IM; Lim JK; Fried MW
    Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive monitoring of patients with chronic hepatitis C.
    Fontana RJ; Lok AS
    Hepatology; 2002 Nov; 36(5 Suppl 1):S57-64. PubMed ID: 12407577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Antiviral Therapy on Serum Activity of Angiotensin Converting Enzyme in Patients with Chronic Hepatitis C.
    Husic-Selimovic A; Sofic A; Huskic J; Bulja D
    Med Arch; 2016 Apr; 70(2):92-6. PubMed ID: 27147779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C-related cirrhosis. Current status.
    Conde I; Vinaixa C; Berenguer M
    Med Clin (Barc); 2017 Jan; 148(2):78-85. PubMed ID: 27855947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
    Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
    Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.
    Maan R; van Tilborg M; Deterding K; Ramji A; van der Meer AJ; Wong F; Fung S; Sherman M; Manns MP; Cornberg M; Hansen BE; Wedemeyer H; Janssen HL; de Knegt RJ; Feld JJ
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1821-1830.e6. PubMed ID: 27404965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C.
    Martinez SM; Fernández-Varo G; González P; Sampson E; Bruguera M; Navasa M; Jiménez W; Sánchez-Tapias JM; Forns X
    Aliment Pharmacol Ther; 2011 Jan; 33(1):138-48. PubMed ID: 21083589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals.
    Akuta N; Kobayashi M; Suzuki F; Sezaki H; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
    Oncology; 2016; 91(6):341-347. PubMed ID: 27694754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.